Truist Financial
ABVX

Truist Financial’s Abivax ABVX Stock Holding History

Truist Financial’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$825K Buy
6,194
+327
+6% +$37K ﹤0.01% 1887
2026
Q1 		$653K Sell
5,867
-454
-7% -$53.7K ﹤0.01% 1919
2025
Q4 		$852K Buy
6,321
+3,232
+105% +$353K ﹤0.01% 1756
2025
Q3 		$262K Buy
+3,089
New +$189K ﹤0.01% 2396

Other funds holding ABVX

NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Truist Financial's ABVX Position: Q2 2026 in Review

Truist Financial increased its Abivax (ABVX) stake by 5.6% in Q2 2026, buying an estimated $37K and bringing the position to 6,194 shares worth $825K. The position accounts for ﹤0.01% of the portfolio, ranked #1887.

Truist Financial first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $852K in Q4 2025. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Truist Financial held 6,194 shares of Abivax worth $825K as of Q2 2026.
  • Truist Financial bought 327 Abivax shares in Q2 2026, an estimated $37K.
  • Abivax made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1887 holding.
  • Truist Financial first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Truist Financial's Abivax position peaked at $852K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.